Arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists covalently bind to the PPARγ ligand binding domain with a unique binding mode
- 14 March 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 64, 128676
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLMActa Crystallographica Section D Structural Biology, 2011
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesisNature Reviews Endocrinology, 2010
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- The Role of PPARs in CancerPPAR Research, 2008
- The Differential Interactions of Peroxisome Proliferator-Activated Receptor γ Ligands with Tyr473 Is a Physical Basis for Their Unique Biological ActivitiesMolecular Pharmacology, 2008
- The Dipeptide H‐Trp‐Glu‐OH Shows Highly Antagonistic Activity against PPARγ: Bioassay with Molecular Modeling SimulationChemBioChem, 2006
- The Nuclear Receptor Corepressors NCoR and SMRT Decrease Peroxisome Proliferator-activated Receptor γ Transcriptional Activity and Repress 3T3-L1 AdipogenesisJournal of Biological Chemistry, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Analysis of temperature factor distribution in high‐resolution protein structuresProtein Science, 1997
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997